Synapse - Find an Expert

33620 Results

10-year survival in patients diagnosed with high-grade epithelial ovarian cancer: A new metric for a new millennium

Meeting Abstract

Filippova, O.; Straubhar, A.; Lugo Santiago, N.; Zivanovic, O.; Gardner, G.; Tew, W.; O'Cearbhaill, R.; Grisham, R.; Sonoda, Y.; Roche, K. L.; more...
Gynecologic Oncology (2021)

Fulltext@MSK | Save

Olaparib treatment in patients with platinum-sensitive relapsed ovarian cancer by BRCA mutation and homologous recombination deficiency status: Secondary safety results from the phase II LIGHT study

Meeting Abstract

Cadoo, K.; Simpkins, F.; Mathews, C.; Altman, A.; Gilbert, L.; Liu, Y.; Black, D.; Munley, J.; Kabil, N.; Bennett, J.; more...
Gynecologic Oncology (2021)

Fulltext@MSK | Save

A novel, out-of-pocket, cost-effectiveness analysis comparing a frontline niraparib-for-all to a biomarker-based strategy in patients with advanced ovarian cancer

Meeting Abstract

Lim, S.; Moss, H.; Havrilesky, L.; O'Cearbhaill, R.; Abu-Rustum, N.; Liang, M.; Wright, J.; Aviki, E.
Gynecologic Oncology (2021)

Fulltext@MSK | Save

Association of BRCA1/2, homologous recombination deficiency, and PD-L1 with clinical outcomes in patients receiving atezolizumab versus placebo combined with carboplatin, paclitaxel, and bevacizumab for newly diagnosed ovarian cancer: Exploratory analyses of IMagyn050/GOG3015/ENGOT-ov39

Meeting Abstract

Landen, C.; Molinero, L.; Sehouli, J.; Miller, A.; Moore, K.; Taskiran, C.; Bookman, M.; Lindemann, K.; Anderson, C.; Berger, R.; more...
Gynecologic Oncology (2021)

Fulltext@MSK | Save

Efficacy of niraparib by timing of surgery and residual disease: A post-hoc analysis of patients in the PRIMA/ENGOT-OV26/GOG-3012 study

Meeting Abstract

O'Cearbhaill, R.; Pérez-Fidalgo, J. A.; Monk, B.; Tusquets, I.; McCormick, C.; Fuentes, J.; Moore, R.; Vulsteke, C.; Shahin, M.; Forget, F.; more...
Gynecologic Oncology (2021)

Fulltext@MSK | Save

CDKN2A loss-of-function genetic alterations in uterine sarcoma: Prognostic implications and potential therapeutic target

Meeting Abstract

Miller, K.; Chui, H.; Chiang, S.; Ellenson, L.; Weigelt, B.; Hensley, M.
Gynecologic Oncology (2021)

Fulltext@MSK | Save

Provider perception of racial healthcare disparities among women with gynecologic malignancies

Meeting Abstract

Dessources, K.; Cowan, R.; Stasenko, M.; Lee, J.; Iasonos, A.; Roche, K. L.; Chapman-Davis, E.; Brown, C.
Gynecologic Oncology (2021)

Fulltext@MSK | Save

Maintenance olaparib for patients with newly diagnosed, advanced ovarian cancer and a BRCA mutation: 5-year follow-up from SOLO1

Meeting Abstract

Bradley, W.; Moore, K.; Colombo, N.; Scambia, G.; Kim, B. G.; Oaknin, A.; Friedlander, M.; Lisyanskaya, A.; Floquet, A.; Leary, A.; more...
Gynecologic Oncology (2021)

Fulltext@MSK | Save

COVID-19 outcomes of patients with gynecologic cancer in New York City: An updated analysis

Meeting Abstract

Lara, O.; Smith, M.; Wang, Y.; O'Cearbhaill, R.; Blank, S.; Kolev, V.; Carr, C.; Knisely, A.; McEachron, J.; Gabor, L.; more...
Gynecologic Oncology (2021)

Fulltext@MSK | Save

A multicenter, open-label, randomized, phase III study to compare the efficacy and safety of lenvatinib in combination with pembrolizumab versus treatment of physician's choice in patients with advanced endometrial cancer

Meeting Abstract

Makker, V.; Colombo, N.; Herráez, A. C.; Santin, A.; Colomba, E.; Miller, D.; Fujiwara, K.; Pignata, S.; Baron-Hay, S.; Ray-Coquard, I.; more...
Gynecologic Oncology (2021)

Fulltext@MSK | Save

33620 Results

People

Groups

Results (33620)

Meeting Abstract

Meeting Abstract

Meeting Abstract

Meeting Abstract

Meeting Abstract

Meeting Abstract

Meeting Abstract

Meeting Abstract

Meeting Abstract

Meeting Abstract